Skip to content

Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function

A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03826121
Enrollment
70
Registered
2019-02-01
Start date
2017-09-15
Completion date
2018-08-10
Last updated
2019-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Function

Keywords

Cognitive Function, Sesam Esamesame Oil Cake

Brief summary

This study was the efficacy and safety of Sesame oil cake extract on improvement of Cognitive Function

Detailed description

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate. 70 subjects were participated in Sesame Oil Cake Extract or placebo group. To evaluate the changes of the evaluation items when Sesame Oil Cake Extract was taken three times a day compared with placebo.

Interventions

DIETARY_SUPPLEMENTSesame Oil Cake Extract

Sesame Oil Cake Extract 1.5 g/day for 12 weeks.

DIETARY_SUPPLEMENTplacebo

placebo for 12 weeks.

Sponsors

Chonbuk National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Those who are at least 60 years of age at screening * Those who word list memory / recollection/ recognition test scores of CERAD -K decrease 1-2 SD number of normal value * Those who agree to voluntary participation and to comply with the Notice after fully hearing and understanding the details of this human trial

Exclusion criteria

* Those with a past history of treatment with Axis I disorder in SCID(Structured Clinical Interview for DSM-IV) which is a structured clinical interview in the Diagnostic and Statistical Manual of Mental Disorders at Screening or who have been treated within the last 3 years * Those with alcohol abuse or dependence within the last 3 months * Those who have clinically significant following severe illness (Epilepsy, mental retardation, brain nervous system diseases, endocrine diseases, blood / malignant tumors, cardiovascular diseases, Crohn's disease, etc.) * Those who shows the following results in the Laboratory test * AST, ALT \> 3 times upper limit of normal range * Other significant laboratory test opinion * Those who take any prescription medicines or herbal medicines within 2 weeks before the first ingestion date or take any OTC or vitamin preparations within 1 week * Those who participate in other human trial within 2 months before the first ingestion * Those who whole blood donation within 1 months before the first ingestion or Component blood donation within 2 weeks * Those who is deemed unsuitable for participating in the human trial due to other reasons

Design outcomes

Primary

MeasureTime frameDescription
Changes of Visual learning test12 weeksVisual learning test was measured in baseline and 12 weeks.
Changes of Visual working memory test12 weeksVisual working memory test was measured in baseline and 12 weeks.
Changes of Verbal learning test12 weeksVerbal learning test was measured in baseline and 12 weeks.

Secondary

MeasureTime frameDescription
Changes of the Montreal Cognitive Assessment(MoCA-K)12 weeksThe cognitive function evaluation using the Montreal Cognitive Assessment(MoCA-K) is a total of 8 items, and evaluates cognitive functions such as time / execution power, vocabulary, memory, attention, sentence, abstraction, delayed recall, and orientation. Time / execution power's total score is 5 points, vocabulary's total score is 3 points, attention's total score is 3 points, sentence's total score is 3 points, abstraction's total score is 2 points, delayed recall's total score is 5 points, orientation's total score is 6 points. It takes about 10 minutes to complete, and the total score is 30 points and total score make sum score. A score of 23 points or more is regarded as normal. If you have less than 6 years of education, add 1 point. It takes about 10 minutes to complete, and the score is 30 points. A score of 23 points or more is regarded as normal. If you have less than 6 years of education, add 1 point.
Changes of beta-amyloid12 weeksBeta-amyloid(pg/mL) was measured in baseline and 12 weeks.
Changes of Oxidation index(8-OHdG)12 weeksOxidation index(8-OHdG)(ng/mL) was measured in baseline and 12 weeks.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026